Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Biotechnology
$11.48
+1.46%
Mkt Cap $767.61M
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$34.75
Range $27.00 – $40.00
Implied Upside
+202.8%
Consensus $34.75 vs current $11.48
NASDAQ·Healthcare·Biotechnology
$11.48
+1.46%
Mkt Cap $767.61M
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$34.75
Range $27.00 – $40.00
+202.8%
Consensus $34.75 vs current $11.48